737 related articles for article (PubMed ID: 17694059)
21. Deacetylase inhibition promotes the generation and function of regulatory T cells.
Tao R; de Zoeten EF; Ozkaynak E; Chen C; Wang L; Porrett PM; Li B; Turka LA; Olson EN; Greene MI; Wells AD; Hancock WW
Nat Med; 2007 Nov; 13(11):1299-307. PubMed ID: 17922010
[TBL] [Abstract][Full Text] [Related]
22. Generation of highly suppressive adaptive CD8(+)CD25(+)FOXP3(+) regulatory T cells by continuous antigen stimulation.
Mahic M; Henjum K; Yaqub S; Bjørnbeth BA; Torgersen KM; Taskén K; Aandahl EM
Eur J Immunol; 2008 Mar; 38(3):640-6. PubMed ID: 18266270
[TBL] [Abstract][Full Text] [Related]
23. Lack of Foxp3 function and expression in the thymic epithelium.
Liston A; Farr AG; Chen Z; Benoist C; Mathis D; Manley NR; Rudensky AY
J Exp Med; 2007 Mar; 204(3):475-80. PubMed ID: 17353370
[TBL] [Abstract][Full Text] [Related]
24. IL-27 inhibits the development of regulatory T cells via STAT3.
Huber M; Steinwald V; Guralnik A; Brüstle A; Kleemann P; Rosenplänter C; Decker T; Lohoff M
Int Immunol; 2008 Feb; 20(2):223-34. PubMed ID: 18156621
[TBL] [Abstract][Full Text] [Related]
25. Rapamycin, not cyclosporine, permits thymic generation and peripheral preservation of CD4+ CD25+ FoxP3+ T cells.
Coenen JJ; Koenen HJ; van Rijssen E; Kasran A; Boon L; Hilbrands LB; Joosten I
Bone Marrow Transplant; 2007 May; 39(9):537-45. PubMed ID: 17351648
[TBL] [Abstract][Full Text] [Related]
26. IL-2 induces in vivo suppression by CD4(+)CD25(+)Foxp3(+) regulatory T cells.
Brandenburg S; Takahashi T; de la Rosa M; Janke M; Karsten G; Muzzulini T; Orinska Z; Bulfone-Paus S; Scheffold A
Eur J Immunol; 2008 Jun; 38(6):1643-53. PubMed ID: 18493984
[TBL] [Abstract][Full Text] [Related]
27. GATA3-driven Th2 responses inhibit TGF-beta1-induced FOXP3 expression and the formation of regulatory T cells.
Mantel PY; Kuipers H; Boyman O; Rhyner C; Ouaked N; Rückert B; Karagiannidis C; Lambrecht BN; Hendriks RW; Crameri R; Akdis CA; Blaser K; Schmidt-Weber CB
PLoS Biol; 2007 Dec; 5(12):e329. PubMed ID: 18162042
[TBL] [Abstract][Full Text] [Related]
28. Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature.
Hill JA; Feuerer M; Tash K; Haxhinasto S; Perez J; Melamed R; Mathis D; Benoist C
Immunity; 2007 Nov; 27(5):786-800. PubMed ID: 18024188
[TBL] [Abstract][Full Text] [Related]
29. Foxp3-dependent programme of regulatory T-cell differentiation.
Gavin MA; Rasmussen JP; Fontenot JD; Vasta V; Manganiello VC; Beavo JA; Rudensky AY
Nature; 2007 Feb; 445(7129):771-5. PubMed ID: 17220874
[TBL] [Abstract][Full Text] [Related]
30. Comment on "Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells".
Verhagen J; Wraith DC
J Immunol; 2010 Dec; 185(12):7129; author reply 7130. PubMed ID: 21127313
[No Abstract] [Full Text] [Related]
31. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression.
Wan YY; Flavell RA
Nature; 2007 Feb; 445(7129):766-70. PubMed ID: 17220876
[TBL] [Abstract][Full Text] [Related]
32. Cutting edge: Intrathymic differentiation of adaptive Foxp3+ regulatory T cells upon peripheral proinflammatory immunization.
Zelenay S; Bergman ML; Paiva RS; Lino AC; Martins AC; Duarte JH; Moraes-Fontes MF; Bilate AM; Lafaille JJ; Demengeot J
J Immunol; 2010 Oct; 185(7):3829-33. PubMed ID: 20817879
[TBL] [Abstract][Full Text] [Related]
33. Characterization of regulatory T cells in patients with dermatomyositis.
Antiga E; Kretz CC; Klembt R; Massi D; Ruland V; Stumpf C; Baroni G; Hartmann M; Hartschuh W; Volpi W; Del Bianco E; Enk A; Fabbri P; Krammer PH; Caproni M; Kuhn A
J Autoimmun; 2010 Dec; 35(4):342-50. PubMed ID: 20843660
[TBL] [Abstract][Full Text] [Related]
34. Protein kinase B/Akt signals impair Th17 differentiation and support natural regulatory T cell function and induced regulatory T cell formation.
Pierau M; Engelmann S; Reinhold D; Lapp T; Schraven B; Bommhardt UH
J Immunol; 2009 Nov; 183(10):6124-34. PubMed ID: 19841181
[TBL] [Abstract][Full Text] [Related]
35. Inducing and expanding regulatory T cell populations by foreign antigen.
Kretschmer K; Apostolou I; Hawiger D; Khazaie K; Nussenzweig MC; von Boehmer H
Nat Immunol; 2005 Dec; 6(12):1219-27. PubMed ID: 16244650
[TBL] [Abstract][Full Text] [Related]
36. IL-2Rbeta links IL-2R signaling with Foxp3 expression.
Soper DM; Kasprowicz DJ; Ziegler SF
Eur J Immunol; 2007 Jul; 37(7):1817-26. PubMed ID: 17559173
[TBL] [Abstract][Full Text] [Related]
37. Differential changes in CD4+ and CD8+ effector and regulatory T lymphocyte subsets in the testis of rats undergoing autoimmune orchitis.
Jacobo P; Guazzone VA; Jarazo-Dietrich S; Theas MS; Lustig L
J Reprod Immunol; 2009 Jul; 81(1):44-54. PubMed ID: 19520436
[TBL] [Abstract][Full Text] [Related]
38. IL-27 controls the development of inducible regulatory T cells and Th17 cells via differential effects on STAT1.
Neufert C; Becker C; Wirtz S; Fantini MC; Weigmann B; Galle PR; Neurath MF
Eur J Immunol; 2007 Jul; 37(7):1809-16. PubMed ID: 17549733
[TBL] [Abstract][Full Text] [Related]
39. Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4(+)CD25(-) cells.
Aarts-Riemens T; Emmelot ME; Verdonck LF; Mutis T
Eur J Immunol; 2008 May; 38(5):1381-90. PubMed ID: 18412171
[TBL] [Abstract][Full Text] [Related]
40. Intra-tumoural regulatory T cells: a potential new target in cancer immunotherapy.
Needham DJ; Lee JX; Beilharz MW
Biochem Biophys Res Commun; 2006 May; 343(3):684-91. PubMed ID: 16563349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
